Leave Your Message

翰宇药业

肽启生命密码,智领健康未来

我们创立于1998年,深耕多肽及小核酸的分子密码破译领域,以AI智药技术培育创新药研发的沃土,通过全产业链布局构建药物开发的宏伟蓝图。如今,我们从研发中心的多肽序列智能设计,到斩获美国FDA首仿认证的国际突破;从高纯度原料药的精准合成,到高质量制剂对全球患者生命健康的守护,我们的创新产品已成功进入30多个国家的医疗体系。依托自主知识产权的技术平台和国际化质量标准,我们正持续为全球患者提供更可及、更优质的治疗选择,让创新药物惠及更多生命。

关于我们

Hybio

Peptide unlocks the code of life, leading the intelligent and healthy future

We are deeply involved in the field of molecular code breaking for peptides and small nucleic acids, cultivating a fertile ground for innovative drug research and development through AI intelligent drug technology, and building a grand blueprint for drug development through the layout of the entire industry chain. Nowadays, we have achieved international breakthroughs from intelligent peptide sequence design in our R&D center to obtaining the first generic certification from the US FDA; Our innovative products have successfully entered the medical systems of over 30 countries, from precise synthesis of high-purity raw materials to the protection of global patients' lives and health through high-quality formulations. Relying on our proprietary intellectual property technology platform and international quality standards, we are continuously providing more accessible and high-quality treatment options for patients worldwide, enabling innovative drugs to benefit more lives.

About Us
01

Advantages

A complete and efficient peptide technology platform

The company has mastered a series of proprietary peptide scale production core technologies that reduce production costs, improve production efficiency, and enhance product quality, as well as leading technologies related to the development of new peptide drugs; Simultaneously established a formulation technology platform for multiple dosage forms; Having a complete and efficient industrialization system for peptide drugs, with profound technical accumulation and rich research and development achievements in the field of peptide drug development.

Company Platform

News

01